Freeport-McMoRan Inc. (FCXO34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 112.54 |
|---|---|
| 52-week range | 68.90 – 137.68 |
| Return, 1 month / 3 months | −9.9% / +5.5% |
| Return, 1 year / 3 years | +54.0% / +108.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 49.6% |
| Worst drawdown (1 year) | -23.6% |
| Average daily value traded | 2.44M BRL |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Freeport-McMoRan is a mining company based in Phoenix, Arizona, in the United States. It explores for, mines and processes copper, gold and molybdenum, and its operations include large open-pit mines in the Americas and Indonesia. Its customers are industrial users of metals, including smelters, manufacturers and refiners around the world. The company also recovers other metals as by-products of its mining and processing activities.
Freeport-McMoRan Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code FCXO34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Freeport-McMoRan Inc. (FCXO34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 112.54 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 446 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.0% and over the last three months it rose 5.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.2% | ||
| From 52-week high | -17.6% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.5% | ||
| 6-month return | 12.0% | ||
| 12-month return, skipping the last month | 70.9% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.6% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 2.44M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | −9.9% |
| 3 months | +5.5% |
| 6 months | +12.0% |
| 1 year | +54.0% |
| 3 years | +108.1% |
| 5 years | +74.6% |
Signals
| 50-day / 200-day average | 122.64 / 111.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2026 | USD 0.1729 |
| 13 Apr 2026 | USD 0.1677 |
| 13 Jan 2026 | USD 0.1767 |
| 13 Oct 2025 | USD 0.1774 |
| 11 Jul 2025 | USD 0.1864 |
| 11 Apr 2025 | USD 0.1907 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.